HER2-targeting antibody–drug conjugate RC48 alone or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world study
Titel:
HER2-targeting antibody–drug conjugate RC48 alone or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world study
Auteur:
Chen, Meiting Yao, Kai Cao, Manming Liu, Hao Xue, Cong Qin, Tao Meng, Lingru Zheng, Zhousan Qin, Zike Zhou, Fangjian Liu, Zhuowei Shi, Yanxia An, Xin